http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019185521-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac3d61110b450f97ef46e8cf2b1c8552 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 |
| filingDate | 2019-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a8e4fc73c171871846d116b7f6059fd |
| publicationDate | 2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2019185521-A1 |
| titleOfInvention | Ergosterol-biosynthesis inhibitor and influenza virus infection |
| abstract | The present invention relates to an ergosterol-biosynthesis inhibitor for use in a method of treatment or prophylaxis of an influenza virus infection in a subject. The ergosterol-biosynthesis inhibitor is a compound comprising at least one 1/-/-1,2,4-triazole-1-yl group and is selected from the group consisting of itraconazole, posaconazole, voriconazole, fluconazole or fosfluconazole. |
| priorityDate | 2018-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 349.